PDCD1 and colorectal cancer: To determine whether DNase I treatment improves the efficacy of PD-1 immunotherapy on tumor-bearing mice through elimination of NETs, we subcutaneously inoculated MC38 colorectal cancer cells into WT syngeneic mice.